Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Performance of the Immunoglobulin G Avidity and Enzyme Immunoassay IgG/IgM Screening Tests for Differentiation of the Clinical Spectrum of Toxoplasmosis

  • Tanyuksel, Mehmet (Division of Medical Parasitology, Department of Microbiology and Clinical Microbiology, Gulhane Military Medical Academy) ;
  • Guney, Cakir (Department of Microbiology and Clinical Microbiology, Gulhane Military Medical School) ;
  • Araz, Engin (Division of Medical Parasitology, Department of Microbiology and Clinical Microbiology, Gulhane Military Medical Academy) ;
  • Saracli, M.Ali (Department of Microbiology and Clinical Microbiology, Gulhane Military Medical School) ;
  • Doganci, Levent (Department of Microbiology and Clinical Microbiology, Gulhane Military Medical School)
  • Published : 2004.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Toxoplasmosis has been well known as an important human infection to consider especially in pregnant women. Although many serologic methods are available, the diagnosis of toxoplasmosis can be extremely difficult. The presence of increased levels of Toxoplasma-specific IgG antibodies indicates an infection, but it does not differentiate between a recent and past infection. The purpose of our study was to compare the performance of the ELISA T. gondii IgG/IgM test, a widely used enzyme-linked immunosorbent assay, to the ELISA IgG avidity method. One hundred and four serum samples (from 38 males and 66 females) were tested and evaluated from symptomatic patients (chorioretinitis, lymphadenopathy), and from women in their first trimester of pregnancy who were suspected of having toxoplasmosis, The high IgG avidity and ELISA IgG antibody levels were in agreement for 51 of the specimens (49.0％). Thirty-eight discrepant (borderline) results from the IgG avidity method were positive for IgM (3 specimens) and IgG (37 specimens). Interestingly, out of the eight serum samples that were positive for both IgG and IgM antibodies, two samples were low IgG avidity, and three samples were borderline. There was no statistically significant relation observed between the results of the IgG avidity method and the ELISA IgG test, and the IgG avidity method and ELISA IgM test (X$^2$=1.987; p=0.370 and X$^2$=2.152; p=0.341, respectively). The IgG avidity method was considered easy to perform and an acceptable approach for the differentiation of discrepant results (recent/chronic) and for the current detection of T. gondii antibodies. We concluded that the determination of IgG avidity is a helpful tool for the diagnosis of the ocular form of toxoplasmosis and it is a safe method for screening this disease in the first trimester of pregnancy.

Keywords

References

  1. Auer, H., A. Vander-Möse, O. Picher, J. Walochnik, and H. Aspöck. 2000. Clinical and diagnostic relevance of the Toxoplasma IgG avidity test in the serological surveillance of pregnant women in Austria. Parasitol. Res. 86, 965-970
  2. Gras, L., R.E. Gilbert, M. Wallon, F. Peyron, and M. Cortina-Borja. 2004. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical and cross-sectional incidence studies. Epidemiol. Infect. 132, 541-548
  3. Jenum, P.A., B. Stray-Pedersen, and A.G. Gundersen. 1997. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G activity. J. Clin. Microbiol. 35, 1972-1977
  4. Jones, J.L., A. Lopez, M. Wilson, J. Schulkin, and R. Gibbs. 2001. Congenital Toxoplasmosis: A review. Obstet. Gynecol. Surv.56, 296-305
  5. Kodjikian, L, I. Hoigne, O. Adam, P. Jacquier, C. Aebi-Ochsner, C. Aebi, and J.G. Garweg. 2004. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr. Infect. Dis. J. 23, 272-274
  6. Lappalainen, M., P. Koskela, M. Koskiniemi, P. Ammala, V. Hiilesmaa, K. Teramo, K.O. Raivio, J.S. Remington, and K. Hedman. 1993. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J. Infect. Dis. 167, 691-697
  7. Lappalainen, M., M. Koskiniemi, V. Hiilesmaa, P. Ammala, K. Teramo, P. Koskela, M. Lebech, K.O. Raivio, and K. Hedman. 1995. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatr. Infect. Dis. J. 14, 354-361
  8. Liesenfeld, O., C. Press, R. Flanders, R. Ramirez, and J.S. Remington. 1996. Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M Toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J. Clin. Microbiol. 34, 2526-2530
  9. Liesenfeld, O., J.G. Montoya, S. Kinney, C. Press, and J.S. Remington. 2001. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J. Infect. Dis. 183, 1248-1253
  10. Liesenfeld, O., C. Press, J.G. Montoya, R. Gill, J.L. Isaac-Renton, K. Hedman, and J.S. Remington. 1997. False-positive results in immunoglobulin M (IgM) Toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J. Clin. Microbiol. 35, 174-178
  11. Marcolino, P.T., D.A.O. Silva, P.G. Leser, M.E. Camargo, and J.R. Mineo. 2000. Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by western blotting. Clin. Diagn. Lab. Immnuol. 7, 384-389
  12. Montoya, J.G., O. Liesenfeld, S. Kinney, C. Press, and J.S. Remington. 2002. VIDAS test for avidity of Toxoplasma specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. 40, 2504-2508
  13. Montoya, J.G. and J.S. Remington. 2000. Toxoplasma gondii, p.2873. In Mandell, G.L., Bennett, J.E., Dolin, R. (eds.), Mandell, Douglas, and Bennetts Principles and Practice of Infectious Disease. Fifth edition, Churchill Livingstone, Philadelphia
  14. Paul, M. 1999. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin. Diagn. Lab. Immunol.6, 514-518
  15. Pelloux, H., E. Brun, G. Vernet, S. Marcillat, M. Jolivet, D. Guergour, H. Fricker-Hidalgo, A. Goullier-Fleuret, and P. Ambroise-Thomas. 1998. Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (BioMerieux). Diagn. Microbiol. Infect. Dis. 32, 69-73
  16. Prince, H.E. and M. Wilson. 2001. Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 8, 904-908
  17. Vogel, N., M. Kirisits, E. Michael, H. Bach, M. Hostetter, K. Boyer, R. Simpson, E. Hofels, J. Hopkins, D. Mack, M.B. Mets, C.N. Swisher, D. Patel, N. Roizen, L. Stein, M. Stein, S. Withers, E. Mui, C. Egwuagu, J. Remington, R.Dorfman, and R. McLeod. 1996. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin. Infect. Dis. 23, 1055-1060
  18. Wong, S.Y. and J.S. Remington. 1994. Toxoplasmosis in pregnancy. Clin. Infect. Dis. 18, 853-861